Related to this topic: Leaflets | Support | Patient+ | Medicines | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Digestants (Pancreatin and Similar Drugs)

Pancreatin

Pancreatin is a digestive enzyme produced by the exocrine glands of the pancreas and is necessary for the digestion of starch, fat and protein.

Indications1

Pancreatin-insufficiency states:

Cautions

The CSM advises that higher strength pancreatin preparations (Nutrizym 22® and Pancreatin HL®) have been associated with the development of large bowel strictures in children with CF aged between 2 and 13.3 Risk factors are: male sex, more severe CF and concomitant laxative use.

High strength pancreatin preparations1
  • These preparations should not be used in children aged 15 years or less.
  • The total dose of pancreatic enzyme supplementation in CF should not exceed 10 000 units of lipase per kg of body weight/day.
  • If new or altered abdominal symptoms develop whilst taking pancreatin preparations, the patient should be reviewed to exclude colonic damage.

Side-effects1

  • Irritation of the perioral skin and buccal mucosa - do not retain in the mouth
  • Perianal irritation with high doses
  • GI side-effects are common - nausea, vomiting, abdominal discomfort
  • Hyperuricaemia and hyperuricosuria are associated with high doses
  • Hypersensitivity reactions are rarer and can occur in those handling the powder as well as those ingesting it.

Using pancreatin supplements1,4

  • Take with food (or immediately before or after) as gastric acid inactivates the enzyme.
  • Reducing gastric acid secretions by taking with a H2-Receptor Antagonist or PPI may improve fat digestion and absorption. However a Cochrane Review found only limited evidence of nutritional benefit but some of improvement in GI symptoms with the use of drugs to reduce gastric acidity in people with cystic fibrosis.5
  • Enteric-coating delivers a higher enzyme concentration in the duodenum (do not chew these capsules).
  • Avoid contact with excess heat . Do not mix with hot fluid or food as this will inactivate the enzyme.
  • Similarly avoid keeping food/liquid mixtures with pancreatin for more than one hour as again the enzyme will become denatured.
  • Dose should be titrated to size, number and consistency of stools.
  • Extra allowance should be made if snacks are taken between meals.


Document references
  1. British National Formulary British Medical Association and Royal Pharmaceutical Society of Great Britain. London.
  2. No authors listed; Management of pancreatic cancer.; Drug Ther Bull. 2003 May;41(5):36-40. [abstract]
  3. Smyth RL, van Velzen D, Smyth AR, et al; Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.; Lancet. 1994 Jan 8;343(8889):85-6. [abstract]
  4. BNF for Children
  5. Ng SM, Jones AP; Drug therapies for reducing gastric acidity in people with cystic fibrosis.; Cochrane Database Syst Rev. 2003;(2):CD003424. [abstract]

Internet and further reading
  • Cystic Fibrosis Trust: Standards for the clinical care of children and adults with cystic fibrosis in the UK
AcknowledgementsEMIS is grateful to Dr Chloe Borton for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 313
Document Version: 2
DocRef: bgp25052
Last Updated: 7 Sep 2007
Review Date: 6 Sep 2008


















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site














Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page